(Q33353609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Mechthild Krause

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michael Baumann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Ala Yaromina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Annegret Dörfler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Wolfgang Eicheler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christina Schütze

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Kristin Gurtner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1019-1028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

Repopulation during fractionated radiotherapy: much has been learned, even more is open.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Biology of interactions: antiepidermal growth factor receptor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Clinical biomarkers of kinase activity: examples from EGFR inhibition trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Molecular mechanisms of radiation-induced accelerated repopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.8.0008

21 January 2018

Identifiers

DOI

10.1211/JPP.60.8.0008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18644194%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference